Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
analytical, anti, BioPharma, block, California, call, cellular, cytokine, differentiation, epithelial, exploit, fee, freestanding, FSB, glucose, hawse, healing, immunology, implicated, improperly, IND, inhibit, insulin, integrin, issuer, mAb, maintenance, Milky, minimum, monoclonal, monotherapy, month, multifunctional, NOL, obesity, overstated, Panorama, solid, TGF, TME, toxicology, UCSF, UK, understated, University, vitro, wound, written
Removed:
Administration, amendment, Australian, British, CFFT, ciliary, collateral, country, Designation, disease, DM, duration, EMA, enrolled, European, exposure, Fast, Food, hypersensitivity, increasing, liquidity, operation, Orphan, patient, portfolio, preserve, remeasured, significantly, stage, sudden, Track, treated, uncured
Filing tables
Filing exhibits
Related press release
CRBP similar filings
Filing view
External links
